The SIEGEL™ TAVR System: 30-Day US Early Feasibility Study Results (Mirus Medical)

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Abbott; Boston Scientific Corporation</li><li>Equity/Stock(s)/Options - DASI Simulations; Opus</li><li>Advisory Board - Picardia; Trisol</li></ul>